Lonzena
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Lonzena
Giovanni Alessio
CEO & Board Member
About Lonzena
Lonzena is a US incorporation that develops and tests cancer antibiotics: either low or zero toxicity compounds including drugs as well as novel non-toxic substances able to kill cancer cells.
$
Lonzena revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Lonzena has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Lonzena has never raised funding before.
Austria
United States
South Africa
United KingdomFrequently asked questions
Lonzena is located in XX.
Lonzena was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Lonzena has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
